| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLCO1B7 CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F AQP10 ABCA3 SLC4A7 TMEM241 SLCO2A1 SLC22A5 SCN5A SCN7A SLC4A10 SLC34A2 SLC46A1 SLC1A2 MFSD10 SLC38A8 | 1.24e-09 | 1180 | 68 | 20 | GO:0022857 |
| GeneOntologyMolecularFunction | transporter activity | SLCO1B7 CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F AQP10 ABCA3 SLC4A7 TMEM241 SLCO2A1 SLC22A5 SCN5A SCN7A SLC4A10 SLC34A2 SLC46A1 SLC1A2 MFSD10 SLC38A8 | 5.67e-09 | 1289 | 68 | 20 | GO:0005215 |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLCO1B7 SLC6A8 SLC4A7 TMEM241 SLCO2A1 SLC4A10 SLC46A1 SLC1A2 MFSD10 SLC38A8 | 5.45e-08 | 293 | 68 | 10 | GO:0008514 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLCO1B7 SLC6A8 SLC4A7 TMEM241 SLCO2A1 SLC22A5 SLC4A10 SLC34A2 SLC46A1 SLC1A2 | 5.99e-08 | 296 | 68 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.20e-07 | 14 | 68 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F SLC4A7 SCN5A SCN7A SLC4A10 SLC34A2 SLC1A2 | 4.50e-07 | 465 | 68 | 11 | GO:0046873 |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLCO1B7 SLC6A8 ABCA3 SLC4A7 TMEM241 SLCO2A1 SLC22A5 SLC4A10 SLC34A2 SLC46A1 SLC1A2 | 5.79e-07 | 477 | 68 | 11 | GO:0022804 |
| GeneOntologyMolecularFunction | symporter activity | 7.75e-07 | 150 | 68 | 7 | GO:0015293 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F SLC4A7 SCN5A SCN7A SLC4A10 SLC34A2 SLC46A1 SLC1A2 | 1.21e-06 | 627 | 68 | 12 | GO:0022890 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F AQP10 SLC4A7 SCN5A SCN7A SLC4A10 SLC34A2 SLC46A1 SLC1A2 | 1.40e-06 | 758 | 68 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.87e-06 | 171 | 68 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F SLC4A7 SCN5A SCN7A SLC4A10 SLC34A2 SLC46A1 SLC1A2 | 2.19e-06 | 664 | 68 | 12 | GO:0008324 |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 3.20e-06 | 119 | 68 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 8.27e-06 | 81 | 68 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F SLC4A7 SCN5A SCN7A SLC4A10 SLC34A2 SLC46A1 SLC1A2 | 1.33e-05 | 793 | 68 | 12 | GO:0015075 |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.80e-05 | 46 | 68 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in cardiac muscle cell action potential | 1.14e-04 | 5 | 68 | 2 | GO:0086007 | |
| GeneOntologyMolecularFunction | sodium:bicarbonate symporter activity | 1.70e-04 | 6 | 68 | 2 | GO:0008510 | |
| GeneOntologyMolecularFunction | modified amino acid transmembrane transporter activity | 1.92e-04 | 33 | 68 | 3 | GO:0072349 | |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 2.10e-04 | 34 | 68 | 3 | GO:0042910 | |
| GeneOntologyMolecularFunction | amide transmembrane transporter activity | 3.94e-04 | 42 | 68 | 3 | GO:0042887 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 4.05e-04 | 9 | 68 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 4.05e-04 | 9 | 68 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 5.58e-04 | 301 | 68 | 6 | GO:0022853 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 7.00e-04 | 207 | 68 | 5 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 7.15e-04 | 208 | 68 | 5 | GO:0005342 | |
| GeneOntologyMolecularFunction | monoatomic cation:bicarbonate symporter activity | 8.70e-04 | 13 | 68 | 2 | GO:0140410 | |
| GeneOntologyMolecularFunction | calcium channel activity | 9.84e-04 | 129 | 68 | 4 | GO:0005262 | |
| GeneOntologyMolecularFunction | prostaglandin transmembrane transporter activity | 1.01e-03 | 14 | 68 | 2 | GO:0015132 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.10e-03 | 343 | 68 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | icosanoid transmembrane transporter activity | 1.17e-03 | 15 | 68 | 2 | GO:0071714 | |
| GeneOntologyMolecularFunction | sodium-independent organic anion transmembrane transporter activity | 1.69e-03 | 18 | 68 | 2 | GO:0015347 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 1.76e-03 | 70 | 68 | 3 | GO:1901618 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 1.76e-03 | 151 | 68 | 4 | GO:0008509 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.76e-03 | 151 | 68 | 4 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.80e-03 | 152 | 68 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | channel activity | 2.02e-03 | 525 | 68 | 7 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 2.05e-03 | 526 | 68 | 7 | GO:0022803 | |
| GeneOntologyMolecularFunction | ankyrin binding | 2.76e-03 | 23 | 68 | 2 | GO:0030506 | |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 2.76e-03 | 23 | 68 | 2 | GO:0005283 | |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 2.76e-03 | 171 | 68 | 4 | GO:0015103 | |
| GeneOntologyMolecularFunction | protein domain specific binding | 2.77e-03 | 875 | 68 | 9 | GO:0019904 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 2.86e-03 | 83 | 68 | 3 | GO:0015101 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.45e-03 | 182 | 68 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 3.52e-03 | 26 | 68 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 3.59e-03 | 184 | 68 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 4.37e-03 | 29 | 68 | 2 | GO:0005416 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 4.70e-03 | 459 | 68 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | alpha-actinin binding | 4.99e-03 | 31 | 68 | 2 | GO:0051393 | |
| GeneOntologyMolecularFunction | bicarbonate transmembrane transporter activity | 5.31e-03 | 32 | 68 | 2 | GO:0015106 | |
| GeneOntologyMolecularFunction | solute:inorganic anion antiporter activity | 5.31e-03 | 32 | 68 | 2 | GO:0005452 | |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 5.53e-03 | 105 | 68 | 3 | GO:0015171 | |
| GeneOntologyMolecularFunction | gated channel activity | 5.60e-03 | 334 | 68 | 5 | GO:0022836 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 6.32e-03 | 35 | 68 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | 7.54e-03 | 507 | 68 | 6 | GO:0060589 | |
| GeneOntologyMolecularFunction | GTPase regulator activity | 7.54e-03 | 507 | 68 | 6 | GO:0030695 | |
| GeneOntologyMolecularFunction | translation initiation factor binding | 7.81e-03 | 39 | 68 | 2 | GO:0031369 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 7.81e-03 | 39 | 68 | 2 | GO:0008187 | |
| GeneOntologyMolecularFunction | actinin binding | 9.43e-03 | 43 | 68 | 2 | GO:0042805 | |
| GeneOntologyMolecularFunction | disulfide oxidoreductase activity | 9.43e-03 | 43 | 68 | 2 | GO:0015036 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.17e-02 | 138 | 68 | 3 | GO:0015297 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLCO1B7 CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F SLC4A7 SPG7 MTOR SLC22A5 SCN5A SCN7A SLC4A10 SLC34A2 PRKCA SLC46A1 SLC1A2 ARF1 | 3.10e-07 | 1374 | 68 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F SLC4A7 SPG7 MTOR SCN5A SCN7A SLC4A10 SLC34A2 PRKCA SLC46A1 SLC1A2 ARF1 | 4.90e-07 | 1115 | 68 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | organic anion transport | SLCO1B7 SLC6A8 SLC4A7 TMEM241 SLCO2A1 SLC4A10 SLC46A1 CPT1A SLC1A2 MFSD10 SLC38A8 | 8.96e-07 | 515 | 68 | 11 | GO:0015711 |
| GeneOntologyBiologicalProcess | sodium ion transport | 3.34e-06 | 275 | 68 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F SLC4A7 SPG7 SLC22A5 SCN5A SCN7A SLC4A10 SLC34A2 SLC46A1 ARF1 | 3.85e-06 | 1000 | 68 | 14 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F SLC4A7 SPG7 MTOR SCN5A SCN7A SLC4A10 SLC34A2 SLC46A1 ARF1 | 4.68e-06 | 1017 | 68 | 14 | GO:0098660 |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 5.52e-06 | 208 | 68 | 7 | GO:0035725 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F SLC4A7 SPG7 SCN5A SCN7A SLC4A10 SLC34A2 SLC46A1 ARF1 | 8.36e-06 | 922 | 68 | 13 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F SLC4A7 SPG7 SCN5A SCN7A SLC4A10 SLC34A2 SLC46A1 ARF1 | 1.05e-05 | 942 | 68 | 13 | GO:0098655 |
| GeneOntologyBiologicalProcess | import across plasma membrane | 1.06e-05 | 230 | 68 | 7 | GO:0098739 | |
| GeneOntologyBiologicalProcess | sodium-independent organic anion transport | 1.52e-05 | 15 | 68 | 3 | GO:0043252 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.88e-05 | 48 | 68 | 4 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.88e-05 | 48 | 68 | 4 | GO:1902656 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1C SLC6A8 CACNA1D CACNA1E CACNA1F SLC4A7 SPG7 SLC22A5 SCN5A SCN7A SLC4A10 SLC34A2 SLC46A1 ARF1 | 2.02e-05 | 1157 | 68 | 14 | GO:0006812 |
| GeneOntologyBiologicalProcess | membrane depolarization during atrial cardiac muscle cell action potential | 3.21e-05 | 3 | 68 | 2 | GO:0098912 | |
| GeneOntologyBiologicalProcess | muscle contraction | 4.99e-05 | 400 | 68 | 8 | GO:0006936 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential involved in contraction | 5.22e-05 | 62 | 68 | 4 | GO:0086002 | |
| GeneOntologyBiologicalProcess | heart contraction | 5.59e-05 | 298 | 68 | 7 | GO:0060047 | |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 5.79e-05 | 23 | 68 | 3 | GO:0086012 | |
| GeneOntologyBiologicalProcess | negative regulation of anion transmembrane transport | 6.40e-05 | 4 | 68 | 2 | GO:1903960 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transmembrane transport | 6.68e-05 | 417 | 68 | 8 | GO:0034765 | |
| GeneOntologyBiologicalProcess | heart process | 7.02e-05 | 309 | 68 | 7 | GO:0003015 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 1.06e-04 | 142 | 68 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 1.06e-04 | 142 | 68 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | response to tetrachloromethane | 1.06e-04 | 5 | 68 | 2 | GO:1904772 | |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 1.06e-04 | 5 | 68 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel | 1.06e-04 | 5 | 68 | 2 | GO:1904879 | |
| GeneOntologyBiologicalProcess | intracellular chemical homeostasis | CACNA1C CACNA1D CACNA1E CACNA1F SLC4A7 SCN7A SLC4A10 SLC34A2 PRKCA SLC46A1 ARF1 | 1.15e-04 | 866 | 68 | 11 | GO:0055082 |
| GeneOntologyBiologicalProcess | regulation of transmembrane transport | 1.30e-04 | 589 | 68 | 9 | GO:0034762 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | 1.50e-04 | 153 | 68 | 5 | GO:0098656 | |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic anion transport | 1.59e-04 | 6 | 68 | 2 | GO:1903792 | |
| GeneOntologyBiologicalProcess | membrane depolarization during AV node cell action potential | 1.59e-04 | 6 | 68 | 2 | GO:0086045 | |
| GeneOntologyBiologicalProcess | actin filament-based process | CACNA1C CACNA1D IQSEC3 SSH1 MTOR FARP1 SCN5A SCN7A CDC42EP2 CASP5 ARF1 | 1.81e-04 | 912 | 68 | 11 | GO:0030029 |
| GeneOntologyBiologicalProcess | visual behavior | 1.87e-04 | 86 | 68 | 4 | GO:0007632 | |
| GeneOntologyBiologicalProcess | cell-cell signaling involved in cardiac conduction | 1.91e-04 | 34 | 68 | 3 | GO:0086019 | |
| GeneOntologyBiologicalProcess | chemical homeostasis | CACNA1C CACNA1D CACNA1E CACNA1F ABCA3 SLC4A7 SCN7A SLC4A10 SLC34A2 PRKCA SLC46A1 MED13 ARF1 | 1.91e-04 | 1249 | 68 | 13 | GO:0048878 |
| GeneOntologyBiologicalProcess | cardiac muscle cell action potential | 1.96e-04 | 87 | 68 | 4 | GO:0086001 | |
| GeneOntologyBiologicalProcess | carboxylic acid transmembrane transport | 2.02e-04 | 163 | 68 | 5 | GO:1905039 | |
| GeneOntologyBiologicalProcess | organic acid transmembrane transport | 2.26e-04 | 167 | 68 | 5 | GO:1903825 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 2.26e-04 | 167 | 68 | 5 | GO:0060048 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 2.26e-04 | 36 | 68 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 2.53e-04 | 93 | 68 | 4 | GO:0086003 | |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell membrane repolarization | 2.96e-04 | 8 | 68 | 2 | GO:0060372 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic anion transmembrane transport | 2.96e-04 | 8 | 68 | 2 | GO:1903959 | |
| GeneOntologyBiologicalProcess | calcium ion import | 3.09e-04 | 98 | 68 | 4 | GO:0070509 | |
| GeneOntologyBiologicalProcess | positive regulation of adenylate cyclase activity | 3.10e-04 | 40 | 68 | 3 | GO:0045762 | |
| GeneOntologyBiologicalProcess | regulation of heart rate by cardiac conduction | 3.34e-04 | 41 | 68 | 3 | GO:0086091 | |
| GeneOntologyBiologicalProcess | cellular homeostasis | CACNA1C CACNA1D CACNA1E CACNA1F SLC4A7 SCN7A SLC4A10 SLC34A2 PRKCA SLC46A1 ARF1 | 3.39e-04 | 981 | 68 | 11 | GO:0019725 |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 3.45e-04 | 183 | 68 | 5 | GO:0006820 | |
| GeneOntologyBiologicalProcess | locomotory behavior | 3.46e-04 | 284 | 68 | 6 | GO:0007626 | |
| GeneOntologyBiologicalProcess | carboxylic acid transport | 3.98e-04 | 410 | 68 | 7 | GO:0046942 | |
| GeneOntologyBiologicalProcess | organic acid transport | 4.10e-04 | 412 | 68 | 7 | GO:0015849 | |
| GeneOntologyBiologicalProcess | modified amino acid transport | 4.12e-04 | 44 | 68 | 3 | GO:0072337 | |
| GeneOntologyBiologicalProcess | muscle system process | 4.25e-04 | 547 | 68 | 8 | GO:0003012 | |
| GeneOntologyBiologicalProcess | amide transport | 4.59e-04 | 420 | 68 | 7 | GO:0042886 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 4.74e-04 | 10 | 68 | 2 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 4.74e-04 | 10 | 68 | 2 | GO:0086015 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription of nucleolar large rRNA by RNA polymerase I | 4.74e-04 | 10 | 68 | 2 | GO:1901838 | |
| GeneOntologyBiologicalProcess | action potential | 5.30e-04 | 201 | 68 | 5 | GO:0001508 | |
| GeneOntologyBiologicalProcess | positive regulation of cyclase activity | 5.33e-04 | 48 | 68 | 3 | GO:0031281 | |
| GeneOntologyBiologicalProcess | positive regulation of lyase activity | 5.66e-04 | 49 | 68 | 3 | GO:0051349 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell membrane repolarization | 5.78e-04 | 11 | 68 | 2 | GO:0099624 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 5.78e-04 | 11 | 68 | 2 | GO:0086070 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 6.04e-04 | 577 | 68 | 8 | GO:0043269 | |
| GeneOntologyBiologicalProcess | circulatory system process | CACNA1C CACNA1D CACNA1E MTOR SLC22A5 SCN5A SCN7A PRKCA SLC1A2 | 6.50e-04 | 733 | 68 | 9 | GO:0003013 |
| GeneOntologyBiologicalProcess | regulation of system process | 6.57e-04 | 734 | 68 | 9 | GO:0044057 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 6.92e-04 | 12 | 68 | 2 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 6.92e-04 | 12 | 68 | 2 | GO:0086016 | |
| GeneOntologyBiologicalProcess | sensory perception | CACNA1D CACNA1E CACNA1F OR2AK2 OR4S1 SLC4A7 OR14A2 SLC4A10 OR56B4 SLC38A8 OR4K14 | 7.14e-04 | 1072 | 68 | 11 | GO:0007600 |
| GeneOntologyBiologicalProcess | striated muscle contraction | 7.49e-04 | 217 | 68 | 5 | GO:0006941 | |
| GeneOntologyBiologicalProcess | modified amino acid metabolic process | 7.65e-04 | 218 | 68 | 5 | GO:0006575 | |
| GeneOntologyBiologicalProcess | response to alkaloid | 7.76e-04 | 125 | 68 | 4 | GO:0043279 | |
| GeneOntologyBiologicalProcess | carnitine metabolic process | 8.16e-04 | 13 | 68 | 2 | GO:0009437 | |
| GeneOntologyBiologicalProcess | actin-mediated cell contraction | 8.23e-04 | 127 | 68 | 4 | GO:0070252 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 8.73e-04 | 129 | 68 | 4 | GO:0002027 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic cation homeostasis | 8.76e-04 | 611 | 68 | 8 | GO:0030003 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | CACNA1C CACNA1E SSH1 MTOR FARP1 NQO1 SLC4A10 PRKCA SLC1A2 ARF1 | 9.63e-04 | 939 | 68 | 10 | GO:0099537 |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase activity | 9.76e-04 | 59 | 68 | 3 | GO:0045761 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 9.76e-04 | 59 | 68 | 3 | GO:0086065 | |
| GeneOntologyBiologicalProcess | intracellular monoatomic ion homeostasis | 9.83e-04 | 622 | 68 | 8 | GO:0006873 | |
| GeneOntologyBiologicalProcess | regulation of membrane depolarization | 1.08e-03 | 61 | 68 | 3 | GO:0003254 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 1.09e-03 | 15 | 68 | 2 | GO:0086067 | |
| GeneOntologyBiologicalProcess | regulation of transcription of nucleolar large rRNA by RNA polymerase I | 1.09e-03 | 15 | 68 | 2 | GO:1901836 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane depolarization | 1.25e-03 | 16 | 68 | 2 | GO:1904181 | |
| GeneOntologyBiologicalProcess | synaptic signaling | CACNA1C CACNA1E SSH1 MTOR FARP1 NQO1 SLC4A10 PRKCA SLC1A2 ARF1 | 1.29e-03 | 976 | 68 | 10 | GO:0099536 |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 1.38e-03 | 249 | 68 | 5 | GO:0008016 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | CACNA1C CACNA1E CACNA1F AQP10 MTOR SCN7A NQO1 SLC4A10 PRKCA CPT1A SLC1A2 PGK1 | 1.51e-03 | 1361 | 68 | 12 | GO:0009628 |
| GeneOntologyBiologicalProcess | regulation of cyclase activity | 1.54e-03 | 69 | 68 | 3 | GO:0031279 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic cation transmembrane transport | 1.57e-03 | 380 | 68 | 6 | GO:1904062 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic anion transport | 1.58e-03 | 18 | 68 | 2 | GO:0044070 | |
| GeneOntologyBiologicalProcess | amino-acid betaine metabolic process | 1.58e-03 | 18 | 68 | 2 | GO:0006577 | |
| GeneOntologyBiologicalProcess | response to light stimulus | 1.61e-03 | 382 | 68 | 6 | GO:0009416 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | 1.64e-03 | 153 | 68 | 4 | GO:0030048 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell communication | 1.77e-03 | 19 | 68 | 2 | GO:0086066 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell to AV node cell signaling | 1.77e-03 | 19 | 68 | 2 | GO:0086026 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle cell action potential | 1.77e-03 | 19 | 68 | 2 | GO:0086014 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor clustering | 1.77e-03 | 19 | 68 | 2 | GO:1903911 | |
| GeneOntologyBiologicalProcess | regulation of lyase activity | 1.81e-03 | 73 | 68 | 3 | GO:0051339 | |
| GeneOntologyBiologicalProcess | ubiquinone metabolic process | 1.96e-03 | 20 | 68 | 2 | GO:0006743 | |
| GeneOntologyBiologicalProcess | regulation of protein modification by small protein conjugation or removal | 2.00e-03 | 271 | 68 | 5 | GO:1903320 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.51e-05 | 46 | 68 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | apical part of cell | SLC6A8 CACNA1D AQP10 SLC4A7 CSPG4 SLC22A5 SLC4A10 SLC34A2 PRKCA SLC46A1 | 2.04e-05 | 592 | 68 | 10 | GO:0045177 |
| GeneOntologyCellularComponent | apical plasma membrane | SLC6A8 CACNA1D AQP10 SLC4A7 CSPG4 SLC22A5 SLC4A10 SLC34A2 SLC46A1 | 2.73e-05 | 487 | 68 | 9 | GO:0016324 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 8.04e-05 | 320 | 68 | 7 | GO:0016323 | |
| GeneOntologyCellularComponent | calcium channel complex | 9.41e-05 | 73 | 68 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | cation channel complex | 1.16e-04 | 235 | 68 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | basal plasma membrane | 1.50e-04 | 354 | 68 | 7 | GO:0009925 | |
| GeneOntologyCellularComponent | brush border membrane | 1.55e-04 | 83 | 68 | 4 | GO:0031526 | |
| GeneOntologyCellularComponent | basal part of cell | 2.25e-04 | 378 | 68 | 7 | GO:0045178 | |
| GeneOntologyCellularComponent | cell projection membrane | 4.95e-04 | 431 | 68 | 7 | GO:0031253 | |
| GeneOntologyCellularComponent | L-type voltage-gated calcium channel complex | 6.74e-04 | 12 | 68 | 2 | GO:1990454 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 7.98e-04 | 223 | 68 | 5 | GO:0098862 | |
| GeneOntologyCellularComponent | perikaryon | 7.98e-04 | 223 | 68 | 5 | GO:0043204 | |
| GeneOntologyCellularComponent | cell body | CACNA1C CACNA1D CACNA1E CACNA1F MTOR NQO1 SLC4A10 CASP5 PRKCA SLC1A2 | 8.01e-04 | 929 | 68 | 10 | GO:0044297 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.37e-03 | 17 | 68 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.43e-03 | 378 | 68 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | neuronal cell body | CACNA1C CACNA1D CACNA1E CACNA1F MTOR NQO1 SLC4A10 CASP5 PRKCA | 1.48e-03 | 835 | 68 | 9 | GO:0043025 |
| GeneOntologyCellularComponent | brush border | 1.52e-03 | 152 | 68 | 4 | GO:0005903 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1C CACNA1D CACNA1E CACNA1F MTOR FARP1 NQO1 SLC4A10 CASP5 PRKCA SLC1A2 | 1.92e-03 | 1228 | 68 | 11 | GO:0036477 |
| GeneOntologyCellularComponent | T-tubule | 2.18e-03 | 79 | 68 | 3 | GO:0030315 | |
| GeneOntologyCellularComponent | axon | 2.30e-03 | 891 | 68 | 9 | GO:0030424 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.54e-03 | 290 | 68 | 5 | GO:0043292 | |
| GeneOntologyCellularComponent | synaptic membrane | 2.82e-03 | 583 | 68 | 7 | GO:0097060 | |
| GeneOntologyCellularComponent | sodium channel complex | 4.00e-03 | 29 | 68 | 2 | GO:0034706 | |
| MousePheno | decreased aerobic running capacity | 2.40e-05 | 15 | 54 | 3 | MP:0003061 | |
| MousePheno | abnormal aerobic fitness | 5.93e-05 | 20 | 54 | 3 | MP:0000348 | |
| Domain | VDCC_a1su_IQ | 4.94e-09 | 7 | 66 | 4 | IPR014873 | |
| Domain | GPHH | 4.94e-09 | 7 | 66 | 4 | PF16905 | |
| Domain | GPHH_dom | 4.94e-09 | 7 | 66 | 4 | IPR031649 | |
| Domain | Ca_chan_IQ | 4.94e-09 | 7 | 66 | 4 | SM01062 | |
| Domain | Ca_chan_IQ | 4.94e-09 | 7 | 66 | 4 | PF08763 | |
| Domain | VDCCAlpha1 | 2.94e-08 | 10 | 66 | 4 | IPR002077 | |
| Domain | CAC1F_C | 4.21e-08 | 3 | 66 | 3 | IPR031688 | |
| Domain | CAC1F_C | 4.21e-08 | 3 | 66 | 3 | PF16885 | |
| Domain | Channel_four-helix_dom | 4.86e-08 | 57 | 66 | 6 | IPR027359 | |
| Domain | - | 4.86e-08 | 57 | 66 | 6 | 1.20.120.350 | |
| Domain | VDCC_L_a1su | 1.68e-07 | 4 | 66 | 3 | IPR005446 | |
| Domain | Ion_trans_dom | 3.05e-06 | 114 | 66 | 6 | IPR005821 | |
| Domain | Ion_trans | 3.05e-06 | 114 | 66 | 6 | PF00520 | |
| Domain | MFS | 3.98e-05 | 108 | 66 | 5 | PS50850 | |
| Domain | MFS_dom | 1.11e-04 | 134 | 66 | 5 | IPR020846 | |
| Domain | Anion_exchange | 1.22e-04 | 5 | 66 | 2 | IPR001717 | |
| Domain | ANION_EXCHANGER_2 | 2.55e-04 | 7 | 66 | 2 | PS00220 | |
| Domain | ANION_EXCHANGER_1 | 2.55e-04 | 7 | 66 | 2 | PS00219 | |
| Domain | Band3_cytoplasmic_dom | 4.36e-04 | 9 | 66 | 2 | IPR013769 | |
| Domain | Band_3_cyto | 4.36e-04 | 9 | 66 | 2 | PF07565 | |
| Domain | - | 4.36e-04 | 9 | 66 | 2 | 3.40.1100.10 | |
| Domain | Na_channel_asu | 5.43e-04 | 10 | 66 | 2 | IPR001696 | |
| Domain | HCO3_cotransp | 5.43e-04 | 10 | 66 | 2 | PF00955 | |
| Domain | HCO3_transpt_C | 5.43e-04 | 10 | 66 | 2 | IPR011531 | |
| Domain | Na_trans_assoc | 5.43e-04 | 10 | 66 | 2 | IPR010526 | |
| Domain | PTrfase/Anion_transptr | 5.43e-04 | 10 | 66 | 2 | IPR016152 | |
| Domain | HCO3_transpt_euk | 5.43e-04 | 10 | 66 | 2 | IPR003020 | |
| Domain | Na_trans_assoc | 5.43e-04 | 10 | 66 | 2 | PF06512 | |
| Domain | OA_transporter | 7.93e-04 | 12 | 66 | 2 | IPR004156 | |
| Domain | OATP | 7.93e-04 | 12 | 66 | 2 | PF03137 | |
| Domain | Pept_C14_p20 | 1.09e-03 | 14 | 66 | 2 | IPR001309 | |
| Domain | Caspase-like_dom | 1.09e-03 | 14 | 66 | 2 | IPR029030 | |
| Domain | CASPASE_P20 | 1.09e-03 | 14 | 66 | 2 | PS50208 | |
| Domain | - | 1.09e-03 | 14 | 66 | 2 | 3.40.50.1460 | |
| Domain | EF-hand-dom_pair | 3.44e-03 | 287 | 66 | 5 | IPR011992 | |
| Domain | IQ_motif_EF-hand-BS | 3.98e-03 | 90 | 66 | 3 | IPR000048 | |
| Domain | Sugar_transporter_CS | 5.70e-03 | 32 | 66 | 2 | IPR005829 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.18e-06 | 6 | 56 | 3 | M47762 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.87e-06 | 23 | 56 | 4 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 2.65e-06 | 25 | 56 | 4 | M47948 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 2.10e-05 | 14 | 56 | 3 | M47692 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 3.51e-05 | 47 | 56 | 4 | M19708 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 4.10e-05 | 238 | 56 | 7 | MM15076 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLCO1B7 ABCA3 SLC4A7 SPG7 SLCO2A1 SLC22A5 SLC4A10 SLC34A2 SLC46A1 SLC1A2 ARF1 | 6.28e-05 | 681 | 56 | 11 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | AQP10 ABCA3 SLC4A7 SPG7 SLCO2A1 SLC22A5 SLC4A10 SLC34A2 SLC46A1 SLC1A2 ARF1 | 1.26e-04 | 736 | 56 | 11 | M27287 |
| Pathway | WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES | 1.45e-04 | 26 | 56 | 3 | M48054 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 2.56e-04 | 78 | 56 | 4 | M1921 | |
| Pathway | REACTOME_PHASE_0_RAPID_DEPOLARISATION | 2.71e-04 | 32 | 56 | 3 | M27455 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 4.43e-04 | 249 | 56 | 6 | M5988 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 6.83e-04 | 10 | 56 | 2 | M27335 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM | 6.83e-04 | 10 | 56 | 2 | M27573 | |
| Pathway | REACTOME_BICARBONATE_TRANSPORTERS | 6.83e-04 | 10 | 56 | 2 | MM15073 | |
| Pathway | KEGG_GNRH_SIGNALING_PATHWAY | 6.85e-04 | 101 | 56 | 4 | M1979 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 6.88e-04 | 178 | 56 | 5 | M2890 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 8.33e-04 | 11 | 56 | 2 | M47958 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 8.81e-04 | 108 | 56 | 4 | M823 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 8.81e-04 | 108 | 56 | 4 | M17034 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 9.12e-04 | 109 | 56 | 4 | MM15074 | |
| Pathway | REACTOME_TRANSPORT_OF_ORGANIC_ANIONS | 9.97e-04 | 12 | 56 | 2 | MM15476 | |
| Pathway | KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION | 1.11e-03 | 115 | 56 | 4 | M9387 | |
| Pubmed | 4.66e-10 | 7 | 68 | 4 | 12900400 | ||
| Pubmed | 1.79e-08 | 15 | 68 | 4 | 20188150 | ||
| Pubmed | 1.79e-08 | 15 | 68 | 4 | 24453333 | ||
| Pubmed | 2.86e-08 | 4 | 68 | 3 | 20937870 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 11296258 | ||
| Pubmed | 7.13e-08 | 5 | 68 | 3 | 15451373 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 3.26e-07 | 139 | 68 | 6 | 16985003 | |
| Pubmed | 3.98e-07 | 8 | 68 | 3 | 28330839 | ||
| Pubmed | 3.98e-07 | 347 | 68 | 8 | 17114649 | ||
| Pubmed | 5.95e-07 | 9 | 68 | 3 | 16382099 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 9.38e-07 | 38 | 68 | 4 | 30786075 | |
| Pubmed | 1.17e-06 | 11 | 68 | 3 | 18809727 | ||
| Pubmed | FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation. | 3.20e-06 | 15 | 68 | 3 | 31285543 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15504744 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21054386 | ||
| Pubmed | Voltage-Gated Cav1 Channels in Disorders of Vision and Hearing. | 3.77e-06 | 2 | 68 | 2 | 25966695 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24086669 | ||
| Pubmed | Differential zinc permeation and blockade of L-type Ca2+ channel isoforms Cav1.2 and Cav1.3. | 3.77e-06 | 2 | 68 | 2 | 26049024 | |
| Pubmed | NQO1/CPT1A promotes the progression of pancreatic adenocarcinoma via fatty acid oxidation. | 3.77e-06 | 2 | 68 | 2 | 37249337 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 19225208 | ||
| Pubmed | Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. | 3.77e-06 | 2 | 68 | 2 | 16706838 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23761887 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 14981074 | ||
| Pubmed | CaV1.2 and CaV1.3 channel hyperactivation in mouse islet β cells exposed to type 1 diabetic serum. | 3.77e-06 | 2 | 68 | 2 | 25292336 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17526649 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12606379 | ||
| Pubmed | Pyrimidine-2,4,6-triones are a new class of voltage-gated L-type Ca2+ channel activators. | 3.77e-06 | 2 | 68 | 2 | 24941892 | |
| Pubmed | Complex Brugada syndrome inheritance in a family harbouring compound SCN5A and CACNA1C mutations. | 3.77e-06 | 2 | 68 | 2 | 25341504 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17981261 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 22826131 | ||
| Pubmed | C-terminal modulator controls Ca2+-dependent gating of Ca(v)1.4 L-type Ca2+ channels. | 3.77e-06 | 2 | 68 | 2 | 16921373 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24470632 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17591920 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24760982 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 20014384 | ||
| Pubmed | PKCα phosphorylation of GLT-1 at Ser562/563 induces glutamate excitotoxicity in ischemia in mice. | 3.77e-06 | 2 | 68 | 2 | 35318310 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 12973680 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 30001160 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 21352396 | ||
| Pubmed | CPT1A modulates PI3K/Akt/mTOR pathway to promote preeclampsia. | 3.77e-06 | 2 | 68 | 2 | 36702079 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 15932895 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 23144896 | ||
| Pubmed | Molecular nature of anomalous L-type calcium channels in mouse cerebellar granule cells. | 3.77e-06 | 2 | 68 | 2 | 17409250 | |
| Pubmed | Neuronal L-type calcium channels open quickly and are inhibited slowly. | 3.77e-06 | 2 | 68 | 2 | 16267232 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24996399 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24849370 | ||
| Pubmed | Structure and functional characterization of neuronal alpha 1E calcium channel subtypes. | 3.77e-06 | 2 | 68 | 2 | 8071363 | |
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17015854 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 17928512 | ||
| Pubmed | 3.77e-06 | 2 | 68 | 2 | 24848473 | ||
| Pubmed | 4.23e-06 | 55 | 68 | 4 | 27997827 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 17767505 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 27733576 | ||
| Pubmed | Voltage gated ion channels blockade is the underlying mechanism of BIMU8 induced cardiotoxicity. | 1.13e-05 | 3 | 68 | 2 | 28552773 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 2173707 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 26831068 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 20457610 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 31233190 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 23338940 | ||
| Pubmed | Genetic dissection of horizontal cell inhibitory signaling in mice in complete darkness in vivo. | 1.13e-05 | 3 | 68 | 2 | 26024096 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 19351867 | ||
| Pubmed | Truncation of murine CaV1.2 at Asp-1904 results in heart failure after birth. | 1.13e-05 | 3 | 68 | 2 | 21832054 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 17289261 | ||
| Pubmed | Potent inhibition of L-type Ca2+ currents by a Rad variant associated with congestive heart failure. | 1.13e-05 | 3 | 68 | 2 | 23973784 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 31302118 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 23045342 | ||
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 32555258 | ||
| Pubmed | Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons. | 1.13e-05 | 3 | 68 | 2 | 24934288 | |
| Pubmed | 1.13e-05 | 3 | 68 | 2 | 22907434 | ||
| Pubmed | Rheb1 is required for mTORC1 and myelination in postnatal brain development. | 1.59e-05 | 25 | 68 | 3 | 21238928 | |
| Pubmed | EGFR signals to mTOR through PKC and independently of Akt in glioma. | 2.25e-05 | 4 | 68 | 2 | 19176518 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 24917592 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 14592810 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 15647998 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 24687990 | ||
| Pubmed | Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1. | 2.25e-05 | 4 | 68 | 2 | 26356530 | |
| Pubmed | Coronin 1B coordinates Arp2/3 complex and cofilin activities at the leading edge. | 2.25e-05 | 4 | 68 | 2 | 17350576 | |
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 18292781 | ||
| Pubmed | 2.25e-05 | 4 | 68 | 2 | 8830050 | ||
| Pubmed | Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. | 2.25e-05 | 4 | 68 | 2 | 17110593 | |
| Pubmed | MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway. | 2.25e-05 | 4 | 68 | 2 | 28923857 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 20093484 | ||
| Pubmed | Human CLEC16A regulates autophagy through modulating mTOR activity. | 3.75e-05 | 5 | 68 | 2 | 28223137 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 23500099 | ||
| Pubmed | Phosphorylation of the novel mTOR substrate Unkempt regulates cellular morphogenesis. | 3.75e-05 | 5 | 68 | 2 | 36509146 | |
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 31663850 | ||
| Pubmed | 3.75e-05 | 5 | 68 | 2 | 12060068 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SLC6A8 TBC1D9B SPG7 SSH1 MYCBP2 MTOR PCNX4 CSPG4 SCN5A MED13 | 5.50e-05 | 1105 | 68 | 10 | 35748872 |
| Pubmed | Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse. | 5.62e-05 | 6 | 68 | 2 | 16029198 | |
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 21224388 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 26686473 | ||
| Pubmed | 5.62e-05 | 6 | 68 | 2 | 23734214 | ||
| Pubmed | Ranking novel cancer driving synthetic lethal gene pairs using TCGA data. | 5.62e-05 | 6 | 68 | 2 | 27438146 | |
| Pubmed | Early Hearing Loss upon Disruption of Slc4a10 in C57BL/6 Mice. | 5.62e-05 | 6 | 68 | 2 | 31001720 | |
| Pubmed | 6.21e-05 | 39 | 68 | 3 | 33059001 | ||
| Pubmed | IQSEC3 SLC4A7 MYCBP2 FARP1 SLC4A10 DLAT PRKCA SLC1A2 CLEC16A PGK1 | 7.07e-05 | 1139 | 68 | 10 | 36417873 | |
| Pubmed | 7.86e-05 | 7 | 68 | 2 | 21198641 | ||
| Pubmed | 8.87e-05 | 371 | 68 | 6 | 15747579 | ||
| Pubmed | 9.64e-05 | 952 | 68 | 9 | 38569033 | ||
| Pubmed | 1.04e-04 | 382 | 68 | 6 | 37249651 | ||
| Interaction | SCN11A interactions | 1.17e-05 | 15 | 61 | 3 | int:SCN11A | |
| GeneFamily | Solute carriers | SLCO1B7 SLC6A8 SLC4A7 SLCO2A1 SLC22A5 SLC4A10 SLC34A2 SLC46A1 SLC1A2 SLC38A8 | 1.54e-07 | 395 | 52 | 10 | 752 |
| GeneFamily | Calcium voltage-gated channel subunits | 8.68e-07 | 26 | 52 | 4 | 253 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-07 | 174 | 68 | 6 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 8.93e-06 | 183 | 68 | 5 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.41e-06 | 185 | 68 | 5 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.41e-06 | 185 | 68 | 5 | 673308ca0514a4d3629d61fe91e9d8fb31b72166 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 191 | 68 | 5 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 191 | 68 | 5 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 192 | 68 | 5 | 27ff3621e177e7932dd44dd6baa81551ea75a874 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.13e-05 | 192 | 68 | 5 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | COVID-19-kidney-FLT1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.15e-05 | 193 | 68 | 5 | 479abb1cd2eb978b8a4fdb900069a6329fc8cade | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.37e-05 | 200 | 68 | 5 | 24fa22fb93c4533a79e5d95d241a60f4b13e5631 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.29e-05 | 127 | 68 | 4 | 9bc55cb9f4bddb274930784d12a83b9dceb35cb7 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-04 | 161 | 68 | 4 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-04 | 161 | 68 | 4 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-04 | 161 | 68 | 4 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | 10x5'v1-week_17-19-Hematopoietic-HSC/MPP_and_pro-HSC/MPP|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.08e-04 | 161 | 68 | 4 | aee74a2e7a8acd2950341963f1c04b59c7862183 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.10e-04 | 162 | 68 | 4 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.24e-04 | 167 | 68 | 4 | 8b223333c0c7a85b5a1af6f2f5b12ee0d94357f6 | |
| ToppCell | facs-Large_Intestine-Distal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-04 | 168 | 68 | 4 | 03896466698a79f7f1ad862cb7e05585260e2a5a | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 171 | 68 | 4 | e7dbee63cc39230aa12e7868ec78a129160c0d22 | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Enterocyte|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.36e-04 | 171 | 68 | 4 | b0d616699e2110ffd6cf1868ed1f1a29f824e1fc | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 172 | 68 | 4 | 0c2d0bb767e5ce089b42ad49e8b303a103de2d5c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.39e-04 | 172 | 68 | 4 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.42e-04 | 173 | 68 | 4 | a7dee23b1d43d3070d502487af319ff81a9a747b | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 174 | 68 | 4 | e5f12831187140e84b9a49e93b2376b9fefb1aec | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-04 | 176 | 68 | 4 | bd5c85b3a4fb88ffe156599f6d224aa7664a513a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-MAIT_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-04 | 178 | 68 | 4 | 0290868dc990878eac5c182fe64968333bc52450 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-04 | 179 | 68 | 4 | 69c74b2ff43b43653005807654953daf21f932ec | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.69e-04 | 181 | 68 | 4 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.76e-04 | 183 | 68 | 4 | 89727b4f65949ed2dce9d2e0228c79fe4280230c | |
| ToppCell | Control-Endothelial_cells-Pulmonary_venous_endothelial_cells|Control / group, cell type (main and fine annotations) | 1.76e-04 | 183 | 68 | 4 | 46be9f96755c7b65aeac061d95d15abeb6466034 | |
| ToppCell | P03-Endothelial-lymphatic_endothelial_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.76e-04 | 183 | 68 | 4 | 113e6d8d4bb271be984af06cd6c22b180425dcfc | |
| ToppCell | COPD-Endothelial-VE_Venous|COPD / Disease state, Lineage and Cell class | 1.80e-04 | 184 | 68 | 4 | 44d716e7ba46a1ed03f5992631289653f8fd7d5e | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 185 | 68 | 4 | 3a4ae836e882e8d29eb0a2dfab5677f10f2d365f | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-04 | 185 | 68 | 4 | 224f0b022c21dd40bf1f7503f00b3107ef958975 | |
| ToppCell | COPD-Endothelial-VE_Peribronchial|COPD / Disease state, Lineage and Cell class | 1.87e-04 | 186 | 68 | 4 | 23c7d0e8372a71546d687278b985f761d282f92f | |
| ToppCell | P07-Endothelial-capillary_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.87e-04 | 186 | 68 | 4 | 72aab20b848dd9e1101a4bc2466e08aed5f8bbb6 | |
| ToppCell | 10x5'-Lung-Lymphocytic_Invariant-Inducer-like-ILC3|Lung / Manually curated celltypes from each tissue | 1.91e-04 | 187 | 68 | 4 | 0e7aa481effdd8c2fbdf8b65852821dec2d92cde | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-1|TCGA-Breast / Sample_Type by Project: Shred V9 | 1.91e-04 | 187 | 68 | 4 | a716b64ca03d9b61da765bf87f065ac9393303f1 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.91e-04 | 187 | 68 | 4 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | Endothelial-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.91e-04 | 187 | 68 | 4 | febe0b99a6a815ce687160a0e7af55228b1d5beb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.91e-04 | 187 | 68 | 4 | a2bf958ea59c359a265bfa437d59315e1920cdd4 | |
| ToppCell | P07-Endothelial-capillary_endothelial_cell-capillary_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.95e-04 | 188 | 68 | 4 | ee8ff134a639deca2bb3027c4d3291f48c12d171 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-04 | 189 | 68 | 4 | e002dbb2138a6264be23f3b8148275a0cef351ef | |
| ToppCell | Control-Endothelial-VE_Venous|Endothelial / Disease state, Lineage and Cell class | 2.03e-04 | 190 | 68 | 4 | 4e30155203b4a8c5e496fcbe9348b67b98ebc625 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-04 | 190 | 68 | 4 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-04 | 190 | 68 | 4 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.03e-04 | 190 | 68 | 4 | a318d80dd5cc33d43048883b0e7844b5aa280aab | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.03e-04 | 190 | 68 | 4 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.11e-04 | 192 | 68 | 4 | c3dda7c48732b0b8bde36de282d64192f5e9b98f | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_Invariant-Inducer-like-ILC3|lymph-node_spleen / Manually curated celltypes from each tissue | 2.11e-04 | 192 | 68 | 4 | e16035b3328f9b1b2e28d234c62ba88387540550 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 193 | 68 | 4 | c0f0052c24b7fe9e21d2bc6c38047a8e755f87b6 | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 193 | 68 | 4 | 1e6e2d786511cc40241197368f5df20c20b882f3 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.16e-04 | 193 | 68 | 4 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.16e-04 | 193 | 68 | 4 | 682ce63b73a7d02eef240673db67058d7507f744 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 194 | 68 | 4 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.20e-04 | 194 | 68 | 4 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.20e-04 | 194 | 68 | 4 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | COVID-19-kidney-PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.24e-04 | 195 | 68 | 4 | a436483fec137584611f86b7a498a4dc2aa19cd3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.24e-04 | 195 | 68 | 4 | ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-04 | 195 | 68 | 4 | 818bc18c5834238e5f733cac6fe928ed0788f57d | |
| ToppCell | 3'-Distal_airway-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-04 | 195 | 68 | 4 | 53b83e16b350100b1d5791a9c42bd98e37cbc0af | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 195 | 68 | 4 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-04 | 195 | 68 | 4 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 68 | 4 | 7cbb19108b4553ef60ef5c230a29de1662c02efe | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 196 | 68 | 4 | 4cd1e6b7a791e11a40b19f971b7011bd11fe6273 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.33e-04 | 197 | 68 | 4 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.33e-04 | 197 | 68 | 4 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Pericyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.33e-04 | 197 | 68 | 4 | 44cd1ece3633a31e8c9b667cd3cbc2749c06f478 | |
| ToppCell | ASK452-Endothelial-Endothelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.38e-04 | 198 | 68 | 4 | e282769f5fa1765bcce79a0ed9d761bf2e14b012 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.38e-04 | 198 | 68 | 4 | 882710bd6215e299257dd3df234292db9a2823ba | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-04 | 198 | 68 | 4 | 3ae1e2b4ca77b94eaa24a8c990780aff47dface6 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.38e-04 | 198 | 68 | 4 | fb70a649e4e2edb32967328c1085dc5999c29a33 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-04 | 198 | 68 | 4 | 3575620db5aeaeb0bdcd7a8ff65c43abd3fa13e4 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-04 | 199 | 68 | 4 | 6e3a226ebba023e3e909d7a7188137da4f1fd7fc | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.42e-04 | 199 | 68 | 4 | d43c605a4ff221cf78d91678c15d2ad20f831c7f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.42e-04 | 199 | 68 | 4 | a270630626df614f8605abddb7dee7c4d74f6149 | |
| ToppCell | ASK452-Endothelial|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.42e-04 | 199 | 68 | 4 | 0bc97a9a78aaafd1554ae6a61356ed9ea4983fa5 | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte-Muscle_pericyte_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-04 | 199 | 68 | 4 | 929f809579368201331d9099d8904b6e3c41797b | |
| ToppCell | Bronchial-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.42e-04 | 199 | 68 | 4 | 854628ce91068093c14bd4d45ba38c41469f3549 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 2.47e-04 | 200 | 68 | 4 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 2.47e-04 | 200 | 68 | 4 | ddfb1f006365bf16203ee49f20200f68220cc288 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.47e-04 | 200 | 68 | 4 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.47e-04 | 200 | 68 | 4 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | COVID-19-Fibroblasts-Vascular_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.47e-04 | 200 | 68 | 4 | c7f82196a0768ad96b1df8b8915bc541fb118a76 | |
| ToppCell | proximal-Endothelial-Bronchial_Vessel_1|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-04 | 200 | 68 | 4 | d034bd210c87b704acf45f50d888497c8737011b | |
| ToppCell | distal-Endothelial-Vein-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-04 | 200 | 68 | 4 | ff88d28162e0231d5dac0e0c6bec98fa8da58a23 | |
| ToppCell | proximal-3-Endothelial-Bronchial_Vessel_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-04 | 200 | 68 | 4 | 0ff4185021ec84b57be13b28495e2f8a4d195eb6 | |
| ToppCell | proximal-Endothelial-Bronchial_Vessel_1-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.47e-04 | 200 | 68 | 4 | e4f6e0b9502eb531f28d605f9dbda6a72a9ed320 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-04 | 200 | 68 | 4 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| Drug | Verapamil | 1.21e-07 | 16 | 67 | 4 | DB00661 | |
| Drug | riluzole | 7.98e-07 | 174 | 67 | 7 | CID000005070 | |
| Drug | lamotrigine | 1.19e-06 | 116 | 67 | 6 | CID000003878 | |
| Drug | verapamil | CACNA1C CACNA1D CACNA1E CACNA1F AHRR ABCA3 SLC22A5 SCN5A SCN7A PRKCA | 1.61e-06 | 490 | 67 | 10 | CID000002520 |
| Drug | bepridil | 1.93e-06 | 126 | 67 | 6 | CID000002351 | |
| Drug | Cinnarizine | 2.02e-06 | 9 | 67 | 3 | DB00568 | |
| Drug | Nimodipine | 2.02e-06 | 9 | 67 | 3 | DB00393 | |
| Drug | CNS 1145 | 2.63e-06 | 33 | 67 | 4 | CID000190902 | |
| Drug | IHC-64 | 2.63e-06 | 33 | 67 | 4 | CID000162753 | |
| Drug | Mibefradil | 3.95e-06 | 11 | 67 | 3 | DB01388 | |
| Drug | procaine | 5.94e-06 | 153 | 67 | 6 | CID000004914 | |
| Drug | gabapentin | 1.05e-05 | 169 | 67 | 6 | CID000003446 | |
| Drug | isradipine | 1.15e-05 | 100 | 67 | 5 | CID000003784 | |
| Drug | loperamide | 1.46e-05 | 105 | 67 | 5 | CID000003954 | |
| Drug | NSC7524 | 1.60e-05 | 182 | 67 | 6 | CID000005657 | |
| Drug | Ethylene Chlorohydrin | 1.61e-05 | 17 | 67 | 3 | ctd:D005023 | |
| Drug | sodium | CACNA1C CACNA1D SLC4A7 MTOR SLC22A5 SCN5A SCN7A NQO1 SLC34A2 PRKCA SLC46A1 SLC1A2 | 1.76e-05 | 944 | 67 | 12 | CID000000923 |
| Drug | Isradipine | 1.93e-05 | 18 | 67 | 3 | ctd:D017275 | |
| Drug | glutamate | CACNA1C CACNA1D CACNA1E CACNA1F SLC4A7 MTOR MARS1 NQO1 PRKCA CPT1A SLC1A2 PGK1 | 2.12e-05 | 962 | 67 | 12 | CID000000611 |
| Drug | Cinildipine | 2.24e-05 | 56 | 67 | 4 | CID000002752 | |
| Drug | (endo-N-8-methyl-8-azabicyclo-(3.2.1)oct-3-yl)-2,3-dihydro-3-isopropyl-2-oxo-1H-benzimidazol-1-carboxamide | 2.55e-05 | 3 | 67 | 2 | ctd:C070189 | |
| Drug | Azacyclonol [115-46-8]; Down 200; 15uM; PC3; HT_HG-U133A | 2.72e-05 | 200 | 67 | 6 | 6298_DN | |
| Drug | RH 1 | 2.76e-05 | 59 | 67 | 4 | CID000394347 | |
| Drug | nilvadipine | 2.95e-05 | 60 | 67 | 4 | CID000004494 | |
| Drug | dibenz(a,c)anthracene | 3.12e-05 | 21 | 67 | 3 | CID000009164 | |
| Drug | IAA-94 | 3.15e-05 | 61 | 67 | 4 | CID000003667 | |
| Drug | lercanidipine | 3.58e-05 | 63 | 67 | 4 | CID000065866 | |
| Drug | enzacamene | 3.94e-05 | 129 | 67 | 5 | ctd:C038939 | |
| Drug | AC1L1TJF | 4.30e-05 | 66 | 67 | 4 | CID000003377 | |
| Drug | phenytoin | 4.53e-05 | 219 | 67 | 6 | CID000001775 | |
| Drug | gallopamil | 4.57e-05 | 67 | 67 | 4 | CID000001234 | |
| Drug | NSC-686960 | 5.10e-05 | 4 | 67 | 2 | CID000192816 | |
| Drug | AC1L2AC7 | 5.13e-05 | 69 | 67 | 4 | CID000068733 | |
| Drug | octylmethoxycinnamate | 5.62e-05 | 139 | 67 | 5 | ctd:C118580 | |
| Drug | Barium | 6.06e-05 | 72 | 67 | 4 | ctd:D001464 | |
| Drug | CAS 298-57-7 | 6.40e-05 | 73 | 67 | 4 | CID000002761 | |
| Drug | ethosuximide | 6.75e-05 | 74 | 67 | 4 | CID000003291 | |
| Drug | Dantrolene-13C3 | 6.87e-05 | 145 | 67 | 5 | CID000002951 | |
| Drug | NCDC | 7.57e-05 | 28 | 67 | 3 | CID000001583 | |
| Drug | Bay K 8644 | 8.07e-05 | 150 | 67 | 5 | CID000002303 | |
| Drug | nisoldipine | 8.29e-05 | 78 | 67 | 4 | CID000004499 | |
| Drug | Nisoldipine | 8.48e-05 | 5 | 67 | 2 | DB00401 | |
| Drug | B 874-67 | 8.48e-05 | 5 | 67 | 2 | CID000195466 | |
| Drug | nemadipine-A | 8.48e-05 | 5 | 67 | 2 | CID002856102 | |
| Drug | Nilvadipine | 8.48e-05 | 5 | 67 | 2 | DB06712 | |
| Drug | methyl beta-aminocrotonate | 8.48e-05 | 5 | 67 | 2 | CID000084253 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 8.72e-05 | 79 | 67 | 4 | CID005287890 | |
| Drug | lindane | 9.14e-05 | 154 | 67 | 5 | CID000000727 | |
| Drug | butylparaben | 1.00e-04 | 157 | 67 | 5 | ctd:C038091 | |
| Drug | CPU-23 | 1.27e-04 | 6 | 67 | 2 | CID003036051 | |
| Drug | N-(1-naphthyl)ethylenediamine | 1.27e-04 | 6 | 67 | 2 | ctd:C008588 | |
| Drug | thiacloprid | 1.37e-04 | 34 | 67 | 3 | CID000115224 | |
| Drug | Aristolochic Acids | 1.39e-04 | 89 | 67 | 4 | ctd:D034341 | |
| Drug | NBQX | 1.45e-04 | 90 | 67 | 4 | CID003272523 | |
| Drug | lavendustin A | 1.49e-04 | 171 | 67 | 5 | CID000003894 | |
| Drug | (+/-)-Huperzine A | 1.62e-04 | 36 | 67 | 3 | CID000001253 | |
| Drug | iBVE | 1.62e-04 | 36 | 67 | 3 | CID000007992 | |
| Drug | Ampicillin | 1.64e-04 | 93 | 67 | 4 | ctd:D000667 | |
| Drug | Amlodipine | 1.77e-04 | 7 | 67 | 2 | DB00381 | |
| Drug | Isradipine | 1.77e-04 | 7 | 67 | 2 | DB00270 | |
| Drug | laquinimod | 1.77e-04 | 7 | 67 | 2 | ctd:C476223 | |
| Drug | manidipine | 1.78e-04 | 95 | 67 | 4 | CID000004008 | |
| Drug | mercury | 1.86e-04 | 542 | 67 | 8 | CID000023931 | |
| Drug | AC1L8EX3 | 1.91e-04 | 38 | 67 | 3 | CID000400073 | |
| Drug | U46619 | 1.92e-04 | 285 | 67 | 6 | CID000005618 | |
| Drug | isotetrandrine | 1.93e-04 | 97 | 67 | 4 | CID000005422 | |
| Drug | nitrendipine | 2.01e-04 | 98 | 67 | 4 | CID000004507 | |
| Drug | myristoylcarnitine | 2.36e-04 | 8 | 67 | 2 | CID003413344 | |
| Drug | Nifedipine | 2.36e-04 | 8 | 67 | 2 | DB01115 | |
| Drug | arsenic pentoxide | 2.36e-04 | 8 | 67 | 2 | ctd:C042120 | |
| Drug | 1,5-benzothiazepin-4(5H)-one | 2.36e-04 | 8 | 67 | 2 | CID000358939 | |
| Drug | Nitrendipine | 2.36e-04 | 8 | 67 | 2 | DB01054 | |
| Drug | AC1NPPZW | 2.43e-04 | 103 | 67 | 4 | CID005183170 | |
| Drug | AC1L1DXE | 2.49e-04 | 299 | 67 | 6 | CID000002548 | |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.50e-04 | 191 | 67 | 5 | 5581_DN | |
| Drug | baclofen | 2.50e-04 | 191 | 67 | 5 | CID000002284 | |
| Drug | GSK-3beta Inhibitor VIII; Down 200; 10uM; PC3; HT_HG-U133A | 2.50e-04 | 191 | 67 | 5 | 7070_DN | |
| Drug | Dimercaprol | 2.58e-04 | 42 | 67 | 3 | ctd:D004112 | |
| Drug | dihydropyridine | 2.62e-04 | 193 | 67 | 5 | CID000104822 | |
| Drug | phenanthridinone; Up 200; 51.2uM; MCF7; HT_HG-U133A_EA | 2.62e-04 | 193 | 67 | 5 | 1115_UP | |
| Drug | LY 294002; Down 200; 10uM; MCF7; HT_HG-U133A | 2.68e-04 | 194 | 67 | 5 | 5587_DN | |
| Drug | pyraclofos | 2.72e-04 | 106 | 67 | 4 | CID000093460 | |
| Drug | Isoniazid [54-85-3]; Down 200; 29.2uM; PC3; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 5840_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; PC3; HG-U133A | 2.75e-04 | 195 | 67 | 5 | 1927_UP | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 5665_UP | |
| Drug | Ofloxacin [82419-36-1]; Up 200; 11uM; PC3; HT_HG-U133A | 2.75e-04 | 195 | 67 | 5 | 7372_UP | |
| Drug | Mesoridazine besylate [32672-69-8]; Down 200; 7.4uM; MCF7; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 7017_DN | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; PC3; HT_HG-U133A | 2.81e-04 | 196 | 67 | 5 | 6745_DN | |
| Drug | Azaperone [1649-18-9]; Down 200; 12.2uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 3573_DN | |
| Drug | Doxazosin mesylate [77883-43-3]; Up 200; 7.4uM; HL60; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 3024_UP | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 2.88e-04 | 197 | 67 | 5 | 5483_UP | |
| Drug | Syrosingopine [84-36-6]; Down 200; 6uM; HL60; HG-U133A | 2.95e-04 | 198 | 67 | 5 | 1761_DN | |
| Drug | CP-319743 [172078-87-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.95e-04 | 198 | 67 | 5 | 7532_DN | |
| Drug | fura-2 acetoxymethyl ester | 2.96e-04 | 44 | 67 | 3 | CID003364574 | |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; PC3; HG-U133A | 3.02e-04 | 199 | 67 | 5 | 1889_DN | |
| Drug | 1-alpha-25-dihydroxycholecalciferol | CACNA1C CACNA1D MALT1 SLC4A7 SPG7 SSH1 SLC34A2 PRKCA SLC46A1 EMP1 | 3.08e-04 | 909 | 67 | 10 | CID000002524 |
| Drug | Boldine [476-70-0]; Up 200; 12.2uM; HL60; HT_HG-U133A | 3.09e-04 | 200 | 67 | 5 | 2148_UP | |
| Drug | destomycin A | 3.35e-04 | 112 | 67 | 4 | CID000003659 | |
| Drug | Nifedipine | 3.35e-04 | 112 | 67 | 4 | ctd:D009543 | |
| Drug | 3,4,5-trimethoxybenzoic acid | 3.60e-04 | 47 | 67 | 3 | CID000008357 | |
| Disease | Timothy syndrome (implicated_via_orthology) | 4.27e-08 | 4 | 66 | 3 | DOID:0060173 (implicated_via_orthology) | |
| Disease | Renal carnitine transport defect | 4.93e-06 | 2 | 66 | 2 | C0342788 | |
| Disease | Intellectual Disability | 6.94e-06 | 447 | 66 | 8 | C3714756 | |
| Disease | pulmonary alveolar proteinosis (implicated_via_orthology) | 4.91e-05 | 5 | 66 | 2 | DOID:12120 (implicated_via_orthology) | |
| Disease | Duchenne muscular dystrophy (implicated_via_orthology) | 7.24e-05 | 36 | 66 | 3 | DOID:11723 (implicated_via_orthology) | |
| Disease | Sick Sinus Syndrome | 7.35e-05 | 6 | 66 | 2 | C0037052 | |
| Disease | Brugada syndrome | 1.37e-04 | 8 | 66 | 2 | cv:C1142166 | |
| Disease | renin measurement, hypertension | 1.76e-04 | 9 | 66 | 2 | EFO_0000537, EFO_0010616 | |
| Disease | Disorder of fatty acid metabolism | 1.76e-04 | 9 | 66 | 2 | cv:C0268634 | |
| Disease | nervonoylcarnitine (C24:1) measurement | 1.76e-04 | 9 | 66 | 2 | EFO_0800549 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.19e-04 | 10 | 66 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.19e-04 | 10 | 66 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | lignoceroylcarnitine (C24) measurement | 2.68e-04 | 11 | 66 | 2 | EFO_0800541 | |
| Disease | Shortened QT interval | 2.68e-04 | 11 | 66 | 2 | C0151879 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.21e-04 | 12 | 66 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | dihomo-linolenoylcarnitine (C20:3n3 or 6) measurement | 3.78e-04 | 13 | 66 | 2 | EFO_0800547 | |
| Disease | ximenoylcarnitine (C26:1) measurement | 3.78e-04 | 13 | 66 | 2 | EFO_0800543 | |
| Disease | cerotoylcarnitine (C26) measurement | 3.78e-04 | 13 | 66 | 2 | EFO_0800542 | |
| Disease | anemia (implicated_via_orthology) | 5.08e-04 | 15 | 66 | 2 | DOID:2355 (implicated_via_orthology) | |
| Disease | Non-alcoholic Fatty Liver Disease | 5.26e-04 | 70 | 66 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 5.26e-04 | 70 | 66 | 3 | C3241937 | |
| Disease | diastolic blood pressure, systolic blood pressure | 7.36e-04 | 670 | 66 | 7 | EFO_0006335, EFO_0006336 | |
| Disease | Brugada syndrome | 8.22e-04 | 19 | 66 | 2 | MONDO_0015263 | |
| Disease | Dystonia | 9.58e-04 | 86 | 66 | 3 | C0013421 | |
| Disease | Brugada Syndrome (disorder) | 1.32e-03 | 24 | 66 | 2 | C1142166 | |
| Disease | Calcium channel blocker use measurement | 1.34e-03 | 213 | 66 | 4 | EFO_0009930 | |
| Disease | Cardiac Arrhythmia | 1.43e-03 | 25 | 66 | 2 | C0003811 | |
| Disease | brain ischemia (biomarker_via_orthology) | 1.57e-03 | 102 | 66 | 3 | DOID:2316 (biomarker_via_orthology) | |
| Disease | Streptozotocin Diabetes | 1.85e-03 | 108 | 66 | 3 | C0038433 | |
| Disease | Diabetes Mellitus, Experimental | 1.85e-03 | 108 | 66 | 3 | C0011853 | |
| Disease | Alloxan Diabetes | 1.85e-03 | 108 | 66 | 3 | C0002152 | |
| Disease | lifestyle measurement | 1.92e-03 | 235 | 66 | 4 | EFO_0010724 | |
| Disease | Toxic Encephalitis | 1.92e-03 | 29 | 66 | 2 | C0154659 | |
| Disease | Neurotoxicity Syndromes | 1.92e-03 | 29 | 66 | 2 | C0235032 | |
| Disease | Mental Retardation, X-Linked | 1.92e-03 | 29 | 66 | 2 | C1136249 | |
| Disease | Encephalopathy, Toxic | 1.92e-03 | 29 | 66 | 2 | C0149504 | |
| Disease | Epileptic encephalopathy | 2.06e-03 | 30 | 66 | 2 | C0543888 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TSGFLTMQFQGKLKF | 236 | A9YTQ3 | |
| KGGFLSFLEANMFSV | 2211 | Q6UVK1 | |
| NTSGFNMSFLKLFRA | 1566 | Q15878 | |
| TKGNFFTMFLAGSLA | 51 | Q96PS8 | |
| SFTFVVFKNGKMGLN | 456 | P50416 | |
| KGFDIALNLLFAMAF | 1096 | Q99758 | |
| SSGQMGSFIRLKQFL | 661 | Q53GS7 | |
| MQFGNKIAILSGDFL | 181 | Q86YH6 | |
| MAFTFTGLKLQGSLG | 301 | Q96MT7 | |
| SLLGMQLFGGKFNFD | 671 | O60840 | |
| FQFSSLQQGKMFFLI | 301 | Q14728 | |
| LFTMEKGNRFFLSGA | 86 | P54849 | |
| MKTGNQSFGTDFLLV | 16 | Q8NG84 | |
| ATLNFMKGFPFLLGA | 416 | Q96NT5 | |
| IQHSGLANGIFMKFL | 501 | Q9UDY8 | |
| FFMTLNGAFKTQRQL | 2246 | Q9Y3R5 | |
| LFMTGFGFLLSLNLS | 316 | Q63HM2 | |
| FGFLLSLNLSDMGHK | 321 | Q63HM2 | |
| GTFTISNLGMFGIKN | 561 | P10515 | |
| SNLGMFGIKNFSAII | 566 | P10515 | |
| KLISFGGCMAQIFFL | 91 | Q8NGD5 | |
| MGAKNNVTEFVLFGL | 1 | Q8NGB4 | |
| GPINFTMFLNLFGEK | 81 | Q02045 | |
| KFQAGFLNTTFLLMG | 176 | Q6UWN0 | |
| IGGGMAFTFLKVLNN | 236 | P00558 | |
| GLQDLFSQFGKMLSV | 206 | Q4VXU2 | |
| AKMILFAFGSALAQA | 311 | Q9BZE1 | |
| KSVGLLGMQFQLFEN | 921 | Q9UPP2 | |
| SSLFDLNFQAGFLMK | 226 | P15559 | |
| FVFKATGFIMLRNGL | 146 | Q8NH76 | |
| SKGEFLLNGNFVVTM | 801 | Q9P2N4 | |
| MFGDISFLQGKFHLL | 51 | O14613 | |
| AMFKGILQSGLDNFV | 16 | P51878 | |
| SLLGMQLFGGKFNFD | 666 | Q13936 | |
| LFGKFQTNMAFSLEL | 86 | F2Z3M2 | |
| GKGLQQRMFFLFNDV | 771 | Q9Y4F1 | |
| FKDGMNVLGLIGFFI | 236 | P43004 | |
| MGNIFANLFKGLFGK | 1 | P84077 | |
| FGALLSDQGFDLMNK | 676 | Q9UQ88 | |
| LFAALMSFLTGQLFQ | 506 | Q12912 | |
| FMNGTFFGVQQKVLL | 776 | Q8TDG4 | |
| TGFSFLQIFSKNFEM | 181 | O76082 | |
| LLGMQLFGGKFNFDE | 666 | Q01668 | |
| LFMTQFTQGLKGLRS | 1851 | Q5THK1 | |
| MDQKNGSSFTGFILL | 1 | P59922 | |
| LVTGFLLMGFSNIQK | 6 | Q96R54 | |
| FLFQQLGMLVSFVKS | 1011 | P42345 | |
| NSSFFAGMLEGELNK | 106 | Q8TC99 | |
| FLYMGVSSLKGIQLF | 1041 | Q9Y6M7 | |
| LTDFNFLMVLGKGSF | 336 | P17252 | |
| LIFSIMGVNLFAGKF | 1346 | Q14524 | |
| FGNLFVIGMRSFIKA | 431 | Q8WXD0 | |
| LLMDGQVFTFGSFSK | 1006 | O75592 | |
| FFLEISLGQFMKAGS | 106 | P48029 | |
| TGLVFAFMLGSLFAK | 171 | G3V0H7 | |
| FGLNGTLTGQAFKMS | 211 | Q9UHV7 | |
| FILMKSALGAGLLNF | 31 | A6NNN8 | |
| EGGFSAFNQLKMARF | 281 | Q9UQ90 | |
| SFFMVKGAALFLQQG | 41 | Q8WYL5 | |
| LFFSMFLNIGETFKL | 226 | Q66K14 | |
| NMFVFFLNILRQKSG | 76 | Q2KHT3 | |
| AFQLVGGKMAGQFFS | 121 | O95436 | |
| LFGGILMKRFVFSLQ | 381 | Q92959 | |
| GNIFMFSKVANTILF | 91 | Q9Y320 | |
| GKIQMLDSFLLSLGF | 156 | Q5T4T6 | |
| VFLYMGASSLKGIQF | 941 | Q6U841 | |
| AAGFLRSNKIAALFM | 61 | Q2NKQ1 | |
| FLGFFLMFSTVKLKN | 226 | Q24JQ0 | |
| AMAFDGIIFQGQSLK | 211 | P26368 | |
| AKMNFDNVGNGFLSL | 1121 | Q01118 | |
| GNFINRAGMFVSKFF | 651 | P56192 | |
| TLMFFNTKFFGLQTA | 1211 | Q14202 |